Dossier Hub

addiction

Curated coverage for addiction with top developments, timeline context, and connected threads.

Lead CoverageScience02/04/2026, 15:47:27

The Most Effective Method for Quitting Smoking That Almost Nobody Uses

Varenicline (Champix) has the highest smoking cessation success rate of any approach but is rarely the first thing offered to smokers. Here is the treatment hierarchy and why it matters.

EuroBulletin24 Editorial Desk | Linked source

Dossier Timeline

3 updates

Science02/04/2026, 15:46:11

GLP-1 Drugs Are Helping People Stop Drinking — The Addiction Science Nobody Expected

Patients on Ozempic and similar drugs are spontaneously reporting reduced alcohol cravings and consumption. Here is the neuroscience behind why weight-loss drugs might treat addiction.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:45:56

The New Anti-Pain Drug That Doesn't Cause Addiction Is Changing Everything

Suzetrigine (Journavax) was FDA-approved in January 2025 and is now reshaping pain management. Here is what it is, how it works differently from opioids, and who it could help.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:45:50

The Drug That Was Supposed to Kill Diabetes Just Got Approved for Something Nobody Expected

GLP-1 drugs like Ozempic won FDA approvals for addiction, kidney disease, and heart failure in 2026. Here is the full science behind what these drugs are actually doing to the human body.

EuroBulletin24 Editorial Desk | Linked source